Table 2: Comparison of observed and FRS-predicted CVD risk in patients with psoriasis.

GroupNumber of patientsCVD eventsSIR (95% CI)
ObservedFRS-predicted

Total11978271.71.14 (0.92, 1.42)
Female6323325.71.28 (0.92, 1.79)
Male5654945.91.07 (0.81, 1.41)
Age
 <60 years8793433.51.01 (0.73, 1.41)
 60+ years3184838.11.26 (0.95, 1.68)
No systemic treatment13647161.81.15 (0.91, 1.45)
Any systemic treatment198119.81.12 (0.62, 2.03)

FRS: Framingham risk score; CVD: cardiovascular disease; SIR: standardized incident ratio; CI: confidence interval.